Nucleic Acids Research, 2002, Vol. 30, No. 9 1911-1918
© 2002 Oxford University Press
Design of antisense oligonucleotides stabilized by locked nucleic acids
1Freie Universität Berlin, Institut für Chemie/Biochemie, Thielallee 63, 14195 Berlin, Germany, 2Institute of Bioorganic Chemistry of the Polish Academy of Sciences, Noskowsiego 12, 61794 Poznan, Poland and 3Grünenthal GmbH, Molekulare Pharmakologie, Zieglerstrasse 6, 52078 Aachen, Germany
The design of antisense oligonucleotides containing locked nucleic acids (LNA) was optimized and compared to intensively studied DNA oligonucleotides, phosphorothioates and 2'-O-methyl gapmers. In contradiction to the literature, a stretch of seven or eight DNA monomers in the center of a chimeric DNA/LNA oligonucleotide is necessary for full activation of RNase H to cleave the target RNA. For 2'-O-methyl gapmers a stretch of six DNA monomers is sufficient to recruit RNase H. Compared to the 18mer DNA the oligonucleotides containing LNA have an increased melting temperature of 1.54°C per LNA depending on the positions of the modified residues. 2'-O-methyl nucleotides increase the Tm by only <1°C per modification and the Tm of the phosphorothioate is reduced. The efficiency of an oligonucleotide in supporting RNase H cleavage correlates with its affinity for the target RNA, i.e. LNA > 2'-O-methyl > DNA > phosphorothioate. Three LNAs at each end of the oligonucleotide are sufficient to stabilize the oligonucleotide in human serum 10-fold compared to an unmodified oligodeoxynucleotide (from t1/2 =
1.5 h to t1/2 = ~15 h). These chimeric LNA/DNA oligonucleotides are more stable than isosequential phosphorothioates and 2'-O-methyl gapmers, which have half-lives of 10 and 12 h, respectively.
* To whom correspondence should be addressed. Tel: +49 30 83 85 6002; Fax: +49 30 83 85 6413; Email: erdmann{at}chemie.fu-berlin.deThe authors wish to be known that, in their opinion, the first two authors should be regarded as joint First Authors
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. B. Hansen, N. Fisker, M. Westergaard, L. S. Kjaerulff, H. F. Hansen, C. A. Thrue, C. Rosenbohm, M. Wissenbach, H. Orum, and T. Koch SPC3042: a proapoptotic survivin inhibitor Mol. Cancer Ther., September 1, 2008; 7(9): 2736 - 2745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Levin, D. Fiala, M. F. Samala, J. D. Kahn, and R. J. Peterson Position-dependent effects of locked nucleic acid (LNA) on DNA sequencing and PCR primers Nucleic Acids Res., November 2, 2006; (2006) gkl756v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, M. Corgnali, F. Cannata, L. Perrouault, and C. Giovannangeli Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment Nucleic Acids Res., September 11, 2006; 34(16): 4546 - 4553. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kubota, A. Ohashi, H. Imachi, and H. Harada Improved In Situ Hybridization Efficiency with Locked-Nucleic-Acid-Incorporated DNA Probes Appl. Envir. Microbiol., August 1, 2006; 72(8): 5311 - 5317. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Rapozzi, S. Cogoi, and L. E. Xodo Antisense locked nucleic acids efficiently suppress BCR/ABL and induce cell growth decline and apoptosis in leukemic cells. Mol. Cancer Ther., July 1, 2006; 5(7): 1683 - 1692. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kierzek, A. Ciesielska, K. Pasternak, D. H. Mathews, D. H. Turner, and R. Kierzek The influence of locked nucleic acid residues on the thermodynamic properties of 2'-O-methyl RNA/RNA heteroduplexes Nucleic Acids Res., September 9, 2005; 33(16): 5082 - 5093. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, M. Corgnali, L. Perrouault, V. Roig, U. Asseline, M. D. Sorensen, B. R. Babu, J. Wengel, and C. Giovannangeli Intercalator conjugates of pyrimidine locked nucleic acid-modified triplex-forming oligonucleotides: improving DNA binding properties and reaching cellular activities Nucleic Acids Res., July 27, 2005; 33(13): 4223 - 4234. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Chan, A. M. Krichevsky, and K. S. Kosik MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells Cancer Res., July 15, 2005; 65(14): 6029 - 6033. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Andrieu-Soler, M. Casas, A.-M. Faussat, C. Gandolphe, M. Doat, D. Tempe, C. Giovannangeli, F. Behar-Cohen, and J.-P. Concordet Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs Nucleic Acids Res., July 7, 2005; 33(12): 3733 - 3742. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Brunet, P. Alberti, L. Perrouault, R. Babu, J. Wengel, and C. Giovannangeli Exploring Cellular Activity of Locked Nucleic Acid-modified Triplex-forming Oligonucleotides and Defining Its Molecular Basis J. Biol. Chem., May 20, 2005; 280(20): 20076 - 20085. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. D. Charlier, G. F. Ball, and J. Balthazart Inhibition of Steroid Receptor Coactivator-1 Blocks Estrogen and Androgen Action on Male Sex Behavior and Associated Brain Plasticity J. Neurosci., January 26, 2005; 25(4): 906 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Elmén, Håk. Thonberg, K. Ljungberg, M. Frieden, M. Westergaard, Y. Xu, B. Wahren, Z. Liang, H. Ørum, T. Koch, et al. Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality Nucleic Acids Res., January 14, 2005; 33(1): 439 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Valoczi, C. Hornyik, N. Varga, J. Burgyan, S. Kauppinen, and Z. Havelda Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes Nucleic Acids Res., December 14, 2004; 32(22): e175 - e175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Opalinska, A. Kalota, L. K. Gifford, P. Lu, K.-Y. Jen, P. I. Pradeepkumar, J. Barman, T. K. Kim, C. R. Swider, J. Chattopadhyaya, et al. Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules Nucleic Acids Res., October 28, 2004; 32(19): 5791 - 5799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Schmidt, S. Borkowski, J. Kurreck, A. W. Stephens, R. Bald, M. Hecht, M. Friebe, L. Dinkelborg, and V. A. Erdmann Application of locked nucleic acids to improve aptamer in vivo stability and targeting function Nucleic Acids Res., October 27, 2004; 32(19): 5757 - 5765. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nulf and D. Corey Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs) Nucleic Acids Res., July 19, 2004; 32(13): 3792 - 3798. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Darfeuille, J. B. Hansen, H. Orum, C. D. Primo, and J.-J. Toulme LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1 Nucleic Acids Res., June 4, 2004; 32(10): 3101 - 3107. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Yoo, E. Bochkareva, A. Bochkarev, T.-C. Mou, and D. M. Gray 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro Nucleic Acids Res., April 2, 2004; 32(6): 2008 - 2016. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Di Giusto and G. C. King Strong positional preference in the interaction of LNA oligonucleotides with DNA polymerase and proofreading exonuclease activities: implications for genotyping assays Nucleic Acids Res., February 18, 2004; 32(3): e32 - e32. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ittig, S. Liu, D. Renneberg, D. Schumperli, and C. J. Leumann Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA Nucleic Acids Res., January 15, 2004; 32(1): 346 - 353. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Mong, N. Devidze, A. Goodwillie, and D. W. Pfaff Reduction of lipocalin-type prostaglandin D synthase in the preoptic area of female mice mimics estradiol effects on arousal and sex behavior PNAS, December 9, 2003; 100(25): 15206 - 15211. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frieden, S. M. Christensen, N. D. Mikkelsen, C. Rosenbohm, C. A. Thrue, M. Westergaard, H. F. Hansen, H. Orum, and T. Koch Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA Nucleic Acids Res., November 1, 2003; 31(21): 6365 - 6372. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. L. Hertoghs, J. H. Ellis, and I. R. Catchpole Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA Nucleic Acids Res., October 15, 2003; 31(20): 5817 - 5830. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Schubert, D. C. Gul, H.-P. Grunert, H. Zeichhardt, V. A. Erdmann, and J. Kurreck RNA cleaving '10-23' DNAzymes with enhanced stability and activity Nucleic Acids Res., October 15, 2003; 31(20): 5982 - 5992. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Grunweller, E. Wyszko, B. Bieber, R. Jahnel, V. A. Erdmann, and J. Kurreck Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2'-O-methyl RNA, phosphorothioates and small interfering RNA Nucleic Acids Res., June 15, 2003; 31(12): 3185 - 3193. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koizumi, K. Morita, M. Daigo, S. Tsutsumi, K. Abe, S. Obika, and T. Imanishi Triplex formation with 2'-O,4'-C-ethylene-bridged nucleic acids (ENA) having C3'-endo conformation at physiological pH Nucleic Acids Res., June 15, 2003; 31(12): 3267 - 3273. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fluiter, A. L. M. A. ten Asbroek, M. B. de Wissel, M. E. Jakobs, M. Wissenbach, H. Olsson, O. Olsen, H. Oerum, and F. Baas In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides Nucleic Acids Res., February 1, 2003; 31(3): 953 - 962. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Braasch, Y. Liu, and D. R. Corey Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design Nucleic Acids Res., December 1, 2002; 30(23): 5160 - 5167. [Abstract] [Full Text] [PDF] |
||||






